End-of-day quote
Other stock markets
|
||
- USD | - |
Mar. 27 | North American Morning Briefing : Stocks Edge -2- | DJ |
Mar. 25 | Marker Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar TapImmune Inc.
Upcoming events on TapImmune Inc.
Past events on TapImmune Inc.
2024-04-01 | Hematologic Malignancies Global Summit |
2024-03-26 10:00 am | H.C. Wainwright Cell Therapy Virtual Conference |
2024-03-25 05:45 pm | Q4 2023 Earnings Release |
2024-01-09 | Non Dilutive Funding Summit |
2024-01-07 | Biotech Showcase |
2023-11-09 05:00 pm | Q3 2023 Earnings Release |
2023-09-13 08:30 am | H.C. Wainwright Global Investment Conference |
2023-08-14 04:30 pm | Q2 2023 Earnings Release |
2023-06-06 09:00 am | Annual General Meeting |
2023-03-22 08:10 am | Q4 2022 Earnings Release |
2022-11-10 04:05 pm | Q3 2022 Earnings Release |
2022-09-15 09:20 am | Cantor Fitzgerald Cell & Gene Therapy Conference |
2022-08-11 04:22 pm | Interim 2022 Earnings Release |
2022-05-24 09:00 am | Annual General Meeting |
2022-05-13 07:00 am | Q1 2022 Earnings Release |
2022-05-05 08:45 pm | International Society for Cell & Gene Therapy Meeting - Abstract Number : 506 |
2022-05-05 08:45 pm | International Society for Cell & Gene Therapy Meeting - Abstract Number : 936 |
2022-05-05 08:45 pm | International Society for Cell & Gene Therapy Meeting - Abstract Number : 515 |
2022-05-05 08:45 pm | International Society for Cell & Gene Therapy Meeting - Abstract Number : 937 |
2022-03-17 05:45 pm | FY 2021 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,21 0,00 - | 0,47 0,48 -3.46% | 1,24 0,00 - | 9,01 9,00 0.15% |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -22,5 -23,2 2.92% | -28,9 -27,8 -3.86% | -39,5 -40,5 2.49% | 0,00 0,00 - |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,4 -22,2 3.26% | -28,7 -27,7 -3.56% | -41,9 -42,3 0.95% | 0,00 0,00 - |
Net income Million USD | Released Forecast Spread | -21,4 -22,2 3.26% | -28,7 -27,7 -3.56% | -41,9 -42,3 0.95% | 0,00 0,00 - |
EPS USD | Released Forecast Spread | -4,70 -4,86 3.29% | -6,10 -5,90 -3.39% | -5,50 -5,73 3.93% | -3,58 -3,60 0.56% |
Announcement Date | 12/03/20 | 09/03/21 | 17/03/22 | 22/03/23 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1,24 0,00 - | 0,96 0,00 - | 0,79 2,50 -68.38% | 3,95 0,27 1381.07% | 3,31 0,00 - |
EBIT Million USD | Released Forecast Spread | -9,76 -10,8 9.21% | -9,79 -11,2 12.55% | -9,28 -8,72 -6.46% | -7,02 -11,3 37.7% | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,76 -10,8 9.38% | -9,91 -11,2 11.25% | -9,24 -8,74 -5.81% | -6,92 -10,9 36.23% | |
Net income Million USD | Released Forecast Spread | -9,76 -10,8 9.38% | -9,91 -11,2 11.25% | -9,24 -8,74 -5.81% | -6,92 -10,9 36.23% | |
EPS USD | Released Forecast Spread | -1,10 -1,28 13.73% | -1,20 -1,33 10% | -1,10 -1,05 -4.76% | -0,80 -1,30 38.46% | -3,27 -1,00 -227% |
Announcement Date | 17/03/22 | 13/05/22 | 11/08/22 | 10/11/22 | 22/03/23 |
2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
2024-05-01 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-01 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for TapImmune Inc.
Today | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
2024-04-29 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
2024-04-28 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
2024-04-28 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
2024-04-28 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
2024-04-28 | MORPHOSYS AG: Q1 2024 Earnings Release |
2024-04-26 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
- Stock Market
- Equities
- MRKR Stock
- Stock
- Calendar TapImmune Inc.